Option Care Health, Amedisys offer antibody therapy
By HME News Staff
Updated 9:10 AM CST, Wed January 6, 2021
BATON ROUGE, La., and BANNOCKBURN, Ill. – Option Care Health has partnered with Amedisys, a provider of home health, hospice and personal care, to provide COVID antibody infusion therapy in skilled nursing and assisted living facilities. In December, the National Home Infusion Association announced a pilot program with Operation Warp Speed and the Department of Health and Human Services to expand access to Bamlanivimab, which is being used to treat mild to moderate COVID-19 in adults and pediatrics who are at high risk for progressing to severe symptoms or hospitalization. “We are proud to collaborate with Amedisys, a leader in home health and hospice services, along with NHIA and leaders of Operation Warp Speed, to expand access to vital therapies for one of the most vulnerable populations,” said Option Care Health CEO John Rademacher. “Combining the extraordinary capabilities of two industry leaders to solve a critical healthcare challenge is truly humbling.”
Comments